Chargement en cours…

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary /

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process i...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Auteur principal: Caruso, Denise, 1956- (rapporteur.)
Collectivité auteur: Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products (Workshop)
Autres auteurs: English, Rebecca A. (rapporteur.), Claiborne, Anne B. (rapporteur.)
Format: Électronique Actes de congrès eBook
Langue:Inglés
Publié: Washington, D.C. : National Academies Press, [2014]
Sujets:
Accès en ligne:Texto completo
Table des matières:
  • Introduction
  • Identifying and characterizing uncertainty
  • The regulators' challenge
  • Basic methodologies and applications for understanding and evaluating uncertainty
  • Communicating uncertainty
  • Final reflections on ways to characterize and communicate uncertainty.